Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Diabetes raises risk of prostate cancer mortality in obese men

Key clinical point: Diabetes was associated with prostate cancer-specific mortality in obese men, but not in nonobese men.

Major finding: Among obese men, diabetes was significantly associated with increased risk of prostate cancer-specific mortality in a multivariate analysis (adjusted hazard ratio 3.06).

Study details: The data come from a cohort of 4,688 men who underwent radical prostatectomy between 1988 and 2017.

Disclosures: The study was supported by the National Institutes of Health. The researchers had no financial conflicts to disclose.


Source: Kelkar S et al. JNCI Cancer Spectr. 2021 Mar 9. doi: 10.1093/jncics/pkab023.